vilyfijohy.wordpress.com
The Buford, Ga.-based surgical products and cancer treatmentsdcompany (NYSE: TGX) had net income of $607,000 and earninga of 2 cents a share, compared with net incomer of $1.6 million and earnings of 5 cente a share in the first quarterf of 2008. The results for the first quarter of 2009 reflecf the investment the company made in its researc anddevelopment program, IT systems and other Theragenics said. Research and development spendinb was up more than 350 percentto First-quarter revenue rose 32 percent to a quarterl company record $20.1 million. The increasee was primarily the result of the inclusion of resultxsfrom , which it bought in July 2008.
“Wer believe that recording our highesy quarterlyrevenue ever, especially in the current economic environment, is a good start for 2009,” said M. Christins Jacobs, chairman and CEO, in an earningas statement. “We have maintained profitability while investinv in our important strategic Our R&D initiative is well underway and our information technology program was initiated in the first She added that variabilitu in the company’s surgical products businessz and the recession will continue to make it difficulyt to predict 2009 and 2010.
No comments:
Post a Comment